THIOGUANINE NUCLEOTIDES: OPTIMISING THIOPURINE THERAPY IN INFLAMMATORY BOWEL DISEASE (A DGH PERSPECTIVE)

被引：0
|
作者：
Pee, L. [1 ]
Gera, A. [1 ]
Bedwell, T. [1 ]
Saxena, V. [1 ]
Curtis, H. [1 ]
Loganayagam, A. [1 ]
机构：
[1] S London Healthcare NHS Trust, London, England
来源：
GUT | 2012年 / 61卷
关键词：
D O I：
10.1136/gutjnl-2012-302514c.104
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A226 / A227
页数：3
相关论文
共 50 条
  • [1] Thiopurine therapy in inflammatory bowel disease
    Ha, Christina
    Dassopoulos, Themistocles
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) : 575 - 588
  • [2] Effectiveness and safety of thioguanine in thiopurine-naive Inflammatory Bowel Disease patients
    Crouwel, F.
    Bayoumy, A. B.
    Mulder, C. J. J.
    Peters, J. H. C.
    Boekema, P. J.
    Derijks, L. J. J.
    De Boer, S. Y.
    van de Meeberg, P. C.
    Ahmad, I.
    Buiter, H. J. C.
    de Boer, N. K.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I529 - I529
  • [3] Optimizing Thiopurine Therapy in Inflammatory Bowel Disease
    Chevaux, Jean-Baptiste
    Peyrin-Biroulet, Laurent
    Sparrow, Miles P.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (06) : 1428 - 1435
  • [4] Effectiveness and safety of thioguanine in thiopurine-naive Inflammatory Bowel Disease patients
    Crouwel, F.
    Bayoumy, A. B.
    Mulder, C. J. J.
    Peters, J. H. C.
    Boekema, P. J.
    Derijks, L. J. J.
    De Boer, S. Y.
    de Meeberg, P. C. van
    Ahmad, I.
    Buiter, H. J. C.
    de Boer, N. K.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I529 - I529
  • [5] Metabolite measurement for thiopurine therapy in inflammatory bowel disease
    Sanchez Rodriguez, E.
    Rios Leon, R.
    Flores de Miguel, A.
    Guerrero Garcia, A.
    Albillos Martinez, A.
    Lopez Sanroman, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S314 - S314
  • [6] Towards optimal thiopurine therapy for inflammatory bowel disease
    van Liere, Elsa L. S. A.
    de Boer, Nanne K. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (06) : 792 - 793
  • [7] Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease
    Jonason, David E.
    Sievers, Tyson
    Trocke, Lindsay
    Abraham, James M.
    Vaughn, Byron P.
    CROHNS & COLITIS 360, 2020, 2 (03) : 1 - 7
  • [8] Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease
    Sanchez Rodriguez, Eugenia
    Rios Leon, Raquel
    Mesonero Gismero, Francisco
    Albillos, Agustin
    Lopez-Sanroman, Antonio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (10): : 629 - 635
  • [9] IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE
    Nawaz, Ahmad
    Glick, Laura
    Li, Darrick
    Gaidos, Jill
    Proctor, Deborah
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2022, 162 (03) : S107 - S108
  • [10] Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
    Cornish, Jack S.
    Wirthgen, Elisa
    Daebritz, Jan
    FRONTIERS IN MEDICINE, 2020, 7
12345